Skip to main content
Journal of the American Society of Nephrology : JASN logoLink to Journal of the American Society of Nephrology : JASN
. 2012 Nov 8;23(12):1987–2000. doi: 10.1681/ASN.2012040394

Immature Renal Dendritic Cells Recruit Regulatory CXCR6+ Invariant Natural Killer T Cells to Attenuate Crescentic GN

Jan-Hendrik Riedel *, Hans-Joachim Paust *, Jan-Eric Turner *, André P Tittel , Christian Krebs *, Erik Disteldorf *, Claudia Wegscheid , Gisa Tiegs , Joachim Velden §, Hans-Willi Mittrücker , Natalio Garbi , Rolf AK Stahl *, Oliver M Steinmetz *, Christian Kurts , Ulf Panzer *,
PMCID: PMC3507367  PMID: 23138484

Abstract

Immature renal dendritic cells (DCs) are protective early in murine crescentic GN, but the mechanisms underlying this protection are unknown. Here, depletion of DCs reduced the recruitment of invariant natural killer T (iNKT) cells, which attenuate GN, into the kidney in the early stage of experimental crescentic GN. More than 90% of renal iNKT cells expressed the chemokine receptor CXCR6, and renal DCs produced high amounts of the cognate ligand CXCL16 early after induction of nephritis, suggesting that renal DC-derived CXCL16 might attract protective CXCR6+ iNKT cells. Consistent with this finding, CXCR6-deficient mice exhibited less iNKT cell recruitment and developed nephritis that was more severe, similar to the aggravated nephritis observed in mice depleted of immature DCs. Finally, adoptive transfer of CXCR6-competent NKT cells ameliorated nephritis. Taken together, these results suggest an immunoprotective mechanism involving immature DCs, CXCL16, CXCR6, and regulatory iNKT cells, which might stimulate the development of new therapeutic strategies for GN.


GN, as a disease category, is one of the leading causes of progressive renal failure leading to ESRD.1 Among the different types of GN, crescentic GN is the most aggressive form with the worst prognosis. Crescentic GN represents a heterogeneous collection of disease entities, such as ANCA-associated GN and antiglomerular basement membrane (anti-GBM) nephritis.2 Cell-mediated renal damage is, however, a fundamental characteristic of each form of crescentic GN.3,4

Nephrotoxic nephritis (NTN) is a well established murine model of crescentic GN.5 In this model, a sheep antiserum raised against kidney cortical components is injected into mice, resulting in activation of Th1 and Th17 cells in lymphatic organs. Because of their specificity, sheep Igs are preferentially deposited in the kidney, inducing tissue destruction by infiltrating activated Th1 and Th17 cells.68 These cells subsequently activate intrarenal macrophages and drive neutrophil recruitment, causing renal tissue injury.9

Dendritic cells (DCs) are professional antigen-presenting cells that play a pivotal role in the priming and activation of effector T cells, but under certain circumstances, they might also protect against an overwhelming inflammatory response by less well characterized mechanisms. Renal DCs form an extensive parenchymal network that spans the entire tubulointerstitium, ensuring complete surveillance of the kidney to protect it, for example, against infections ascending through the tubular system. Despite their absence from glomeruli, renal DCs are also involved in GN by capturing glomerular antigens or antigens filtered in glomeruli and presenting them to T effector cells, thereby triggering an inflammatory mononuclear infiltrate in the tubulointerstitium that drives renal disease.10,11 It is important to note that renal DCs only exert this pathogenic effect when nephritis becomes chronic (DC maturation).12 At steady state and in acute GN, they can also mediate anti-inflammatory and disease-attenuating effects.13 Generally, immature DCs are thought to induce immune tolerance, and this finding is thought to result from the absence of costimulatory signals.14,15 It is unclear whether this tolerance causes the protective function of immature kidney DCs.

Recent studies showed that renal DCs significantly contribute to the early production of chemokines and other inflammatory mediators, which regulates the recruitment of leukocytes into the inflamed kidney.16 We were, therefore, interested in studying whether renal DCs promote the infiltration of potentially anti-inflammatory leukocyte subsets in the early course of experimental GN (NTN) and characterizing the underlying mechanisms.

Results

DC Depletion Reduced the Recruitment of Anti-Inflammatory Invariant Natural Killer T Cells in Experimental GN

To evaluate the protective mechanisms of DCs in early stages of NTN, CD11c+ DCs were depleted on day 3 after induction of nephritis by injecting CD11c.LuciDTR17 mice with diphtheria toxin (DTx). After 24 hours, renal leukocyte composition was analyzed. As expected, the number of renal DCs was reduced in the DTx group under both control and nephritic conditions (1.9×105±0.4×105 [Con] versus 3.5×104±1.7×104 [DTx], P<0.001; 2.2×105±0.3×105 [NTN] versus 1.1×105±0.4×105 [DTx + NTN], P<0.05) (Figure 1A, left panel). Another interesting finding is that the recruitment of invariant natural killer T (iNKT) cells (defined as CD45+CD1d-Tetramer+ [loaded with αGalCer analog PBS-57] TCRβ+) into the inflamed kidney was significantly reduced after DC depletion (NTN: 2.5×104±0.3×104 versus 1.4×104±0.09×104, P<0.01) (Figure 1A, center panel), whereas the proportion of other immune cells, such as CD3+ T cells (Figure 1A, right panel) and CD11b+ macrophages (data not shown), remained unchanged. DTx-induced DC depletion had no effect on systemic numbers of iNKT cells in CD11cLuciDTR mice (Supplemental Figure 1).

Figure 1.

Figure 1.

DC depletion reduces the recruitment of anti-inflammatory iNKT cells in experimental GN. (A) Quantification of FACS analyses of renal DCs (CD45+MHCII+CD11c+), iNKT (CD45+TCRβ+CD1d-Tetramer+), and T cells (CD45+CD3+) at day 4 of NTN 1 day after DTx injection (numbers represent total cells/kidney; n=3–4/group). (B) Real-time RT-PCR analysis of FACS-sorted iNKT cells for IL-4, IL-10, TGFβ, and IFNγ isolated from kidneys of nephritic wild-type mice and wild-type controls (n=3–13/group). Bars represent means ± SD (*P<0.05, **P<0.01, ***P<0.001).

A role for NKT and iNKT cells in the suppressive activity of immature DCs is supported by previous studies showing that these cells can ameliorate experimental GN.18,19 In agreement with these results, real-time PCR analysis of FACS-sorted iNKT cells from the kidneys of nephritic wild-type mice showed increased expression of the anti-inflammatory mediators IL-4, IL-10, and TGFβ but not the proinflammatory mediator IFNγ compared with untreated control mice. Expression of IL-17 was not detectable (data not shown; IL-4: 4.6-fold versus controls; IL-10: 5.9-fold versus controls; TGFβ: 15.2-fold versus controls; IFNγ: 1.8-fold versus controls) (Figure 1B).

CXCR6 Is Highly Expressed on Renal iNKT Cells

The regulation of renal iNKT cell infiltration is largely unknown. Several chemokine receptors, including CXCR3, CCR5, CCR6, and CXCR6, have been reported to promote NKT and iNKT cell trafficking under inflammatory conditions.20 We, therefore, analyzed the expression profile of these chemokine receptors in renal iNKT cells. More than 90% of renal iNKT cells during the early stages of NTN were CXCR6-positive, whereas CXCR3 (9%), CCR6 (19%), and CCR5 (11%) expression was much less frequent (Figure 2, A and B). By contrast, only about 40% of renal CD4+ T cells and CD8+ T cells were CXCR6+, and less than 10% of CD11b+ macrophages and CD19+ B cells showed CXCR6 expression (data not shown). The specificity of CXCR6 staining was confirmed by simultaneous analysis of renal leukocytes from nephritic CXCR6-deficient mice. These findings suggest a role for CXCR6 in iNKT cell recruitment to the kidney in early NTN.

Figure 2.

Figure 2.

CXCR6 and CXCL16 expression in experimental GN. (A) Representative FACS analysis of CXCR6 expression on isolated renal iNKT cells, defined as CD1d-Tetramer+TCRβ+, gated for CD45+ cells at day 8 of NTN. CXCR6-deficient mice were used as a specificity control. (B) Quantification of FACS analyses for different chemokine receptors on renal iNKT cells (n=6–9/group). (C and D) Real-time RT-PCR analysis of renal (C) CXCL16 and (D) CXCR6 expression in wild-type mice at different time points after induction of NTN (n=4–5/group). (E) Representative photographs of in situ hybridizations with a specific cRNA probe for CXCL16 of control and nephritic wild-type mice at day 6 of NTN. Original magnification, ×400. (F) Representative photograph of a kidney section from a nephritic wild-type mouse immunohistochemically stained for the DC marker CD11c 8 days after induction of NTN. Original magnification, ×400. (G) Real-time RT-PCR analysis of renal CXCL16 expression of DCs isolated from kidneys at days 4 and 8 after induction of nephritis (n=3/group). mRNA levels are expressed as x-fold of wild-type controls. Symbols represent means ± SD.

Renal DCs Produce CXCL16 in the Early Stage of NTN

If CXCR6 is linked to the protective effect of iNKT cells in early NTN, its unique ligand CXCL16 should be expressed in the kidney. To test this hypothesis, we performed real-time PCR to quantify renal CXCL16 expression in nephritic mice at four different time points. mRNA expression of CXCL16 in the kidneys of nephritic wild-type mice peaked 5 days after induction of nephritis and remained elevated until the last time point analyzed (that is, at day 20 after induction of the disease) (Figure 2C). mRNA expression of CXCR6 in the kidneys of nephritic wild-type mice was also increased from day 5 on after induction of nephritis (Figure 2D).

To localize renal CXCL16 expression, we performed in situ hybridization experiments (Figure 2E) and found that mRNA expression of CXCL16 in nephritic mice was predominantly present in periglomerular and tubulointerstitial infiltrates, whereas intraglomerular CXCL16 signals were apparently restricted to cellular crescents and single infiltrating cells in the glomerular tuft. The periglomerular expression pattern of CXCL16 (Figure 2E) was strikingly reminiscent of the location of renal DCs in NTN, which was revealed by immunohistochemical staining for the DC marker CD11c in nephritic mice (Figure 2F).

To test whether renal DCs might contribute to renal CXCL16 production, we analyzed the mRNA levels of this chemokine by quantitative RT-PCR in magnetic activated cell sorting (MACS)-sorted DCs isolated from kidneys at different time points after induction of nephritis. CXCL16 expression by renal DCs peaked at day 4 after induction of nephritis (4.8-fold higher than control) and subsequently declined at day 8 (2.8-fold higher than control) (Figure 2G). This finding suggests that the suppressive modes of action of immature renal DCs and iNKT cells are associated with the CXCL16–CXCR6 axis. These findings do not exclude a contribution of other cells to renal CXCL16 production.

Critical Role of the CXCL16–CXCR6 Axis in Renal iNKT Cell Localization and Function

To determine whether the CXCL16–CXCR6 axis is functionally relevant to NTN, we first analyzed whether CXCR6 deficiency affects the recruitment of iNKT cells to the inflamed kidney. We were able to detect iNKT cells in the kidneys of nephritic wild-type and CXCR6-deficient mice and found that the frequency (Figure 3A) and numbers (not shown) of iNKT cells were reduced in the kidneys of nephritic CXCR6-deficient mice. Quantification of their frequency showed one-half as many Tetramer+TCRβ+ iNKT cells in CXCR6-deficient mice compared with wild-type mice (percent of CD3 cells; WT: 2.5±0.7%; CXCR6−/−: 1.2±0.6%; P<0.01) (Figure 3B).

Figure 3.

Figure 3.

Critical role of the CXCL16–CXCR6 axis for renal iNKT cell localization and function. Representative FACS (A) analysis and (B) quantification of Tetramer+TCRβ+ iNKT cell frequency at day 8 of NTN in wild-type and CXCR6-deficient mice. Results are representative of four independent experiments (n=9/group). (C–F) Representative intracellular IL-4 FACS (C) analysis and (D) quantification as well as IFNγ FACS (E) analysis and (F) quantification of isolated renal leukocytes gated for CD45+TCRβ+Tetramer+ iNKT cells at day 8 of NTN (n=6/group). (G) Cytometric bead assay analysis of IL-4, IL-10, and IFNγ levels of supernatants of 72-hour DC/NKT cell cocultures with or without the addition of a-GalCer (n=3/group). Symbols represent means ± SD (*P<0.05, **P<0.01, ***P<0.001).

In addition to renal iNKT cell localization, the CXCL16–CXCR6 axis might also promote the production of anti- and proinflammatory cytokines, such as IL-4, IL-10, and IFNγ, by iNKT cells. This assumption was investigated by intracellular IL-4 and IFNγ staining of renal iNKT cells of nephritic wild-type and CXCR6-deficient mice. IL-4 expression was significantly reduced in iNKT cells from CXCR6-deficient mice (WT: 24.9±4.9%; CXCR6−/−: 10.7±2.2%; P<0.001) (Figure 3, C and D), whereas IFNγ expression remained unchanged (WT: 57.6±5.5%; CXCR6−/−: 52.3±6.0%) (Figure 3, E and F).

Next, we analyzed whether DC–NKT cell interaction/activation was CXCR6-dependent. We, therefore, purified hepatic NKT cells from wild-type and CXCR6-deficient mice by FACS sorting (purity>95%) followed by stimulation with α-GalCer using mouse myeloid DCs as antigen-presenting cells. The production of IL-4, IL-10, and IFNγ was strongly induced by α-GalCer in DC cocultures with wild-type NKT cells, whereas CXCR6-deficient NKT cells had a significantly reduced capacity to produce IL-4, IL-10, and IFNγ as measured in the supernatants by Cytometric Bead Assay (IL-4: wild-type NKT cells [88.1±18.6 pg/ml] versus CXCR6−/− NKT cells [23.8±2.2 pg/ml], P<0.05; IL-10: wild-type NKT cells [61.9±6.5 pg/ml] versus CXCR6−/− NKT cells [31.2±13.1 pg/ml], P<0.05; IFNγ: wild-type NKT cells [10.5±1.0 ng/ml] versus CXCR6−/− NKT cells [6.9±0.4 ng/ml], P<0.05) (Figure 3G). Furthermore, as determined by ELISA, DC/NKT cell stimulation with α-GalCer led to a high level of CXCL16 protein production (DC + wild-type NKT cells: 1925±126 pg/ml) and tended to be stronger combined with CXCR6-deficient NKT cells (2732±72 pg/ml). NKT cells alone did not produce detectable levels of CXCL16, confirming that DCs were required for CXCL16 formation (data not shown).

CXCR6 Deficiency Aggravates Renal Injury in NTN

To test whether the defect of renal iNKT recruitment and function in nephritic CXCR6−/− mice is of functional importance, we compared the clinical course of experimental GN in wild-type mice with the clinical course in CXCR6-deficient mice. Periodic acid–Schiff (PAS) -stained kidney sections of nephritic mice in the autologous phase at day 8 showed severe focal glomerular and tubular alterations with partial destruction of regular tissue structures (Figure 4A). Glomerular changes included hypercellularity and formation of cellular crescents, capillary aneurysms, and intraglomerular deposition of PAS-positive material. Serial fibrin staining showed the presence of fresh glomerular capillary necrosis (Figure 4A). The tubulointerstitial compartment showed tubular dilatation, necrosis, and atrophy along with protein casts and tubular protein reuptake caused by proteinuria. To quantify renal tissue damage, PAS-stained kidney sections were evaluated for the presence of crescents, glomerular sclerosis (deposition of PAS-positive material), and tubulointerstitial injury (Figure 4, B–D) as previously described.21 The frequency of glomerular crescents at day 8 was significantly increased in nephritic CXCR6-deficient mice compared with the wild-type group (WT: 33.6±9.2%; CXCR6−/−: 45.6±8.5%, P<0.001) (Figure 4B). Nephritic kidneys showed a higher frequency of glomerulosclerosis (WT: 50.3±21.9; CXCR6−/−: 66.3±14.9, P<0.01) (Figure 4C) and considerable tubulointerstitial injury, which was reflected in a significant increase in the interstitial area (WT: 17.5±4.1%; CXCR6−/−: 21.8±4.8%, P<0.001) (Figure 4D).

Figure 4.

Figure 4.

CXCR6 deficiency aggravated renal injury in experimental GN. (A) Representative serial photographs of PAS- and fibrin-stained kidney sections of control, nephritic wild-type, and nephritic CXCR6-deficient mice at day 8 of NTN show glomerular crescent formation, glomerular deposition of PAS-positive material, abundant tubulointerstitial leukocyte infiltrates, and fresh necrosis. Original magnification, ×400. (B–D) Quantification of (B) glomerular crescent formation, (C) glomerular sclerosis, and (D) interstitial area in controls (n=13), nephritic wild-type mice (n=23), and nephritic CXCR6-deficient mice (n=20) 8 days after induction of nephritis. (E) BUN levels, (F) serum creatinine, and (G) albumin-to-creatinine ratio of controls (n=13), nephritic wild-type mice (n=23), and nephritic CXCR6-deficient mice (n=20) 8 days after induction of nephritis. Symbols represent individual data points with median values as horizontal lines (*P<0.05, **P<0.01, ***P<0.001).

BUN and serum creatinine levels of nephritic CXCR6-deficient mice were significantly elevated at day 8 (0.41±0.12 and 173.7±58.4 mg/dl, respectively) compared with the nephritic wild-type group (0.32±0.08 and 132.0±64.2 mg/dl, P<0.01 and P<0.05, respectively) (Figure 4, E and F).

Nephritic wild-type and CXCR6-deficient mice showed a markedly increased albumin-to-creatinine ratio at day 8 after induction of nephritis compared with controls (P<0.001 versus controls). However, there was no statistically significant difference in albumin excretion between nephritic CXCR6-deficient and nephritic wild-type mice (Figure 4G).

Renal T Cell and Monocyte Immune Response in CXCR6-Deficient Mice

Because CXCR6 regulates the trafficking of other immune cell types, we determined the recruitment of leukocytes to the kidneys of nephritic CXCR6-deficient and wild-type mice. In contrast to the reduced frequency of renal iNKT cells, tubulointerstitial CD3 T cell infiltration was significantly increased in nephritic CXCR6-deficient mice (WT: 26.8±9.9/high-power field [hpf]; CXCR6−/−: 33.4±10.6/hpf, P<0.05) (Figure 5, A and B). Infiltration of glomerular T cells, tubulointerstitial F4/80+ macrophages/DCs, and glomerular Mac2+ macrophages did not differ between wild-type and CXCR6-deficient mice (Figure 5C and Supplemental Figure 2, A and B). In addition, infiltrating renal macrophages and DCs in nephritic wild-type and CXCR6-deficient mice were analyzed in more detail by FACS, but no major phenotypical differences in terms of MHCII expression, a marker for antigen presentation, and Ly6C, an activation marker, between these two groups could be observed (Supplemental Figure 2, C and D). The mRNA level of the macrophage and T cell-attracting chemokine CCL2 was significantly upregulated in nephritic CXCR6-deficient mice, whereas no significant differences in renal CCL5, iNOS, IL-12p40, and IL-1β expression could be found (Supplemental Figure 2E).

Figure 5.

Figure 5.

Renal T cell immune response. (A) Representative photographs of kidney sections from control, nephritic wild-type, and CXCR6-deficient mice immunohistochemically stained for the T cell marker CD3 8 days after induction of NTN. Original magnification, ×400. (B and C) Quantification of (B) tubulointerstitial and (C) glomerular CD3+ T cells in nephritic wild-type (n=20), CXCR6−/− mice (n=17), and wild-type controls (n=9). (D) Representative intracellular IFNγ and IL-17 FACS analysis of isolated renal leukocytes, gated for CD4+ T cells, at day 8 of NTN and quantification of (E) Th1 and (F) Th17 cell frequencies (n=4/group). (G) Real-time RT-PCR analysis of renal cytokine expression in nephritic wild-type, CXCR6−/− mice, and wild-type controls (n=9–20 per group) for TNFα, IL-4, IL-10, TGFβ, and CXCL10. mRNA levels are expressed as x-fold of controls. Symbols represent individual data points with median values as horizontal lines (*P<0.05).

To characterize the T cell subtypes in the kidneys of nephritic animals, we performed intracellular flow cytometric analysis for IFNγ+/Th1 and IL-17A+/Th17 cells (Figure 5D). In both nephritic groups, we detected IFNγ+ and IL-17A+ production by renal CD4+ T helper cells but no significant difference between CXCR6-deficient and wild-type mice (Figures 5, D–F).

The renal mRNA levels of the proinflammatory mediators TNF-α and (to a lesser degree) CXCL10 were upregulated in nephritic CXCR6-deficient mice, whereas the anti-inflammatory mediators IL-4, IL-10, and TGFβ were slightly decreased compared with the nephritic wild-type group (Figure 5G).

Next, we were interested to study whether CXCR6 deficiency might result in a defect of renal Treg cell trafficking and thus, an aggravated course of nephritis. FACS analysis revealed that up to 20% of renal Tregs were CXCR6-positive (Figure 6A). However, quantification of tubulointerstitial infiltration of FoxP3+ cells revealed no differences between the wild-type and knockout groups, arguing against a unique role for CXCR6 in renal Treg cell trafficking (Figure 6, B and C). In line with the protein data, we found similar expression of renal FoxP3 mRNA in both groups (Figure 6D).

Figure 6.

Figure 6.

Renal regulatory T cell characteristics. (A) Representative FACS analysis of CXCR6 expression on renal Tregs, defined as CD4+CD25+ cells, gated for CD45+ cells at day 8 of NTN. CXCR6-deficient mice were used as a specificity control (n=5/group). (B) FoxP3 immunohistochemistry of kidney sections from control, nephritic wild-type, and CXCR6-deficient mice at day 8 of NTN. Original magnification, ×400. (C) Quantification of tubulointerstitial FoxP3+ cells in nephritic wild-type (n=20), CXCR6−/− mice (n=17), and wild-type controls (n=9). (D) Real-time RT-PCR of FoxP3 expression in nephritic wild-type (n=20) and CXCR6−/− mice (n=17) as well as wild-type controls (n=9). mRNA levels are expressed as x-fold of controls. Symbols represent individual data points with median values as horizontal lines.

Humoral and Cellular Nephritogenic Immune Responses

Semiquantitative scoring of glomerular sheep and mouse IgG deposition revealed no differences between nephritic wild-type and knockout mice (Figure 7, A and B). In line with this finding, wild-type and CXCR6−/− mice had similar serum titers of anti-sheep IgG, IgG1, and IgG2a antibodies directed against the nephritogenic antigen, which was assessed by ELISA (Figure 7C).

Figure 7.

Figure 7.

Humoral and cellular nephritogenic immune responses. (A and B) Representative photographs and quantification of glomerular sheep IgG deposition at day 2 after induction of NTN and glomerular mouse IgG deposition at day 6 after induction of the nephritis (n=4/group). Original magnification A, ×200; B, ×400. ELISA analysis of (C) circulating serum total IgG, IgG1, and IgG2a levels of wild-type and CXCR6-deficient mice (n=9/group) and (D) IFNγ and IL-17 levels of supernatants of sIgG-stimulated splenocytes at day 8 of NTN (n=6/group). (E and F) FACS quantification of iNKT cells, CD4+ T cells, CD8+ T cells, and macrophages isolated from (E) spleens and (F) lymph nodes of wild-type and CXCR6-deficient mice under control and nephritic conditions (n=3/group). Symbols represent means ± SD.

To address the question of whether CXCR6-deficient mice have an altered systemic cellular immune response, we analyzed splenocytes from nephritic wild-type and CXCR6-deficient mice for the production of IFNγ and IL-17 after restimulation with the nephritogenic antigen. ELISA analyses of the cytokine production from cultured splenocytes showed no significant differences in the Th1-associated IFNγ and Th17-associated IL-17 levels between the two groups (Figure 7D). Furthermore, the frequencies and numbers of CD4+ T cells, CD8+ T cells, CD11b+ macrophages, and most importantly, iNKT cells in the spleens (Figure 7E) and renal lymph nodes (Figure 7F) of nephritic wild-type and CXCR6-deficient mice were almost identical. Taken together, these data strongly argue against an accelerated humoral or cellular systemic nephritogenic immune response or a lymphocyte survival function of the CXCR6–CXCL16 axis as a cause of aggravated nephritis in CXCR6-deficient mice.

Reconstitution of NKT Cells Attenuates Nephritis in CXCR6-Deficient Mice

The aggravation of GN in CXCR6-deficient mice might be caused by the impaired trafficking and function of potentially protective iNKT cells. To prove this hypothesis, we transferred wild-type NKT cells, isolated by FACS sorting from the livers of naive wild-type mice, to wild-type and CXCR6-deficient mice 12 hours before induction of NTN. We isolated hepatic NKT cells for these transfer experiments, because the liver contains the highest rate of NKT cells in the body. To avoid extensive activation of the isolated cells through the tetramer-bound α-GalCer analog PBS57, we used TCRβ and NK1.1 as NKT-defining markers for FACS sorting experiments. FACS analysis of isolated NKT cells before transfer revealed that 95% of the isolated cells were TCRβ+NK1.1+, and over 75% coexpressed an invariant glycolipid antigen-recognizing T cell receptor (Supplemental Figure 3, A and B). In addition, over 80% of the isolated cells were CXCR6-expressing NKT cells (Supplemental Figure 3C). This result was further confirmed by analysis of enhanced green fluorescent protein (eGFP) expression on hepatic NKT cells isolated from CXCR6+/eGFP+ heterozygous mice (Supplemental Figure 3D).

Transfer of 1×106 naive wild-type NKT cells to wild-type and CXCR6-deficient mice 12 hours before induction of nephritis resulted in almost identical histologic tissue injury in both groups at day 8 of nephritis (Figure 8, A and B). In contrast, without NKT cell transfer, CXCR6−/− nephritic mice developed more severe nephritis than wild-type animals (Figure 8, A–C). Most important, renal tissue injury in terms of glomerular crescent formation, glomerular sclerosis, and tubulointerstitial damage and functional parameter (serum creatinine level) was significantly reduced in nephritic CXCR6−/− after the cell transfer compared with CXCR6-deficient animals that received vehicle treatment (Figure 8, A–C), thus showing the protective effect of CXCR6-bearing NKT cells in crescentic GN.

Figure 8.

Figure 8.

Transfer of NKT cells ameliorates nephritis in CXCR6-deficient mice. (A) Representative photographs of PAS-stained kidney sections, (B) quantification of glomerular crescent formation, glomerular sclerosis, and interstitial area, and (C) BUN levels, serum creatinine, and albumin-to-creatinine ratio. (D) Quantification of tubulointerstitial and glomerular CD3+ T cells as well as interstitial F4/80+ macrophages/DCs 8 days after induction of nephritis of wild-type mice (n=6) and nephritic CXCR6-deficient mice (n=6) receiving vehicle treatment as well as wild-type mice (n=9) and CXCR6-deficient mice (n=9) repopulated with 1×106 hepatic wild-type NKT cells 12 hours before the induction of NTN. Symbols represent means ± SD (*P<0.05, **P<0.01, ***P<0.001).

Tubulointerstitial CD3 T cell infiltration, infiltration of glomerular T cells, and infiltration of tubulointerstitial F4/80+ macrophages/DCs did not significantly differ between nephritic wild-type and nephritic CXCR6-deficient mice receiving vehicle treatment or NKT cells (Figure 8D).

Discussion

In experimental crescentic GN, immature kidney DCs are protective13 until they mature, when inflammation becomes chronic.12 The underlying mechanisms remain to be elucidated. We speculated that, in this early phase, DCs might suppress harmful immune responses by recruiting anti-inflammatory leukocytes, and we addressed this hypothesis in NTN, a model of crescentic GN. When we depleted DCs in CD11c.LuciDTRmice with NTN, we noted that iNKT cells but not proinflammatory leukocytes were markedly reduced within the kidney. This finding sparked our interest, because two recent studies had shown a protective role for NKT cells in renal inflammation. Anti-GBM GN was aggravated in NKT cell-deficient CD1d knockout mice, and adoptively transferred NKT cells localized to the inflamed kidney and prevented this phenotype, which was astonishing, because NKT cells cannot recognize antigen in CD1d-deficient mice.18 Nevertheless, Mesnard et al.19 performed this experiment 1 year later in Jα18 knockout mice, which are also deficient in NKT cells but possess CD1d that allows transferred NKT cells to recognize antigen.22 Also, these animals developed more severe nephritis than wild-type mice, verifying the protective role of iNKT cells.19 These findings led us to hypothesize that the protective capacity of immature renal DCs might be mediated through the recruitment of iNKT cells into the kidney.

The in vivo mechanisms of iNKT cell trafficking to the kidney are unknown. iNKT cells are known to express high amounts of CXCR6,2326 and indeed, over 90% of iNKT cells in the inflamed kidney expressed the chemokine receptor CXCR6. We detected message for its unique ligand CXCL16 in immature DCs isolated from the kidney early after induction of nephritis. This finding identified a new cellular source for this chemokine in addition to human tubular cells and podocytes, which had been previously shown to produce the unique CXCR6 ligand, CXCL16.27,28 Moreover, we noted periglomerular CXCL16 expression resembling the periglomerular pattern of renal DCs in both human and experimental GN.11,29 Indeed, iNKT cells failed to accumulate in the kidney of nephritic CXCR6-deficient mice. Interestingly, most of the remaining iNKT cells in the kidneys of nephritic CXCR6-deficient mice are NK1.1+ (Supplement Figure 4), whereas the work by Germanov et al.26 reported that CXCL16 neutralization reduced the accumulation of NK1.1+ but not NK.1.1 iNKT cells in the liver. Most importantly, nephritic CXCR6-deficient mice developed more severe disease. Causality between the reduced iNKT cell recruitment and the aggravated disease in nephritic CXCR6−/− mice was supported by the ability of adoptively transferred CXCR6-competent NKT cells to attenuate disease. Developmental defects in the kidney architecture of CXCR6-deficient mice (Supplemental Figure 5) and an overwhelming humoral or cellular nephritogenic immune response as alternative explanations were ruled out. Thus, our findings reveal a new mechanism by which immature DCs attenuate immune-mediated disease by harnessing iNKT cells with a regulatory functionality.

In experimental GN, two groups independently reported that (i)NKT cell deficiency exacerbates disease.18,19 This finding indicates that (i)NKT cells play a role in suppressing renal autoimmunity, which is in line with our findings. The mechanisms by which regulatory CXCR6+ iNKT cells protect against autoimmune diseases, such as GN, remain to be fully elucidated but likely involve the production of immunomodulatory cytokines, such as IL-4, IL-10, and TGFβ. All of these cytokines have been shown to suppress the model of NTN.13,30,31 The work by Mesnard et al.19 reported that mRNA expression of TGFβ was higher in nephritic wild-type compared with iNKT cell-deficient mouse kidneys and that this reduction contributes to disease exacerbation. In line with these findings, we found increased mRNA expression of IL-4, IL-10, and TGFβ (but not IFNγ) in sorted iNKT cells from nephritic mice. In nephritic CXCR6−/− mice, the number of renal iNKT cells was reduced, and the capacity of CXCR6−/− iNKT cells to produce IL-4 and IL-10 was disturbed. In accordance, the renal expression of IL-4, IL-10, and TGFβ was reduced in nephritic knockout mice, whereas important proinflammatory mediators, such as TNF-α and the chemokines CCL2 and CXCL10, are upregulated and thus, might directly contribute to exacerbation of renal tissue injury in CXCR6−/− mice. However, the exact suppressive mechanism of CXCR6+ iNKT cells may be pinpointed in future studies by, for example, adoptively transferring iNKT cells from cytokine-deficient donor mice or generating iNKT cell-specific CXCR6 knockout mice, which are not yet available. So far, we cannot rule out that CXCR6 deficiency on immune cells other than iNKT cells might contribute to the observed effects in nephritic CXCR6−/− mice. Moreover, it would be interesting to study whether the adoptively transferred NKT cells migrate to the nephritic kidney, which was previously shown in the work by Yang et al.,18 and locally suppress immune-mediated renal inflammation or if the trafficking of NKT cells to secondary lymphatic organs might also be important for their anti-inflammatory properties.

The CXCR6–CXCL16 axis has previously been shown to recruit proinflammatory CD4+ and CD8+ T cells to the inflamed allografts, vessels, and human joints, resulting in tissue damage.3234 In anti-GBM nephritis, blocking CXCL16 with the use of a polyclonal antiserum attenuated the disease, mainly by hindering macrophage influx.35 Furthermore, fibroblasts can express CXCR6, and CXCL16 knockout mice showed reduced fibroblast accumulation in unilateral ureteral obstruction, leading to their protection from renal fibrosis.36 However, recent studies showed that this axis may also exert anti-inflammatory functions. For example, in a murine heart transplant model, the CXCL16–CXCR6 axis plays a pivotal role for the maintenance of transplant tolerance mediated by infiltrating NKT cells.25 Our present study supports this notion by showing aggravation of crescentic GN in CXCR6 knockout mice. It is possible that the CXCL16–CXCR6 axis attracts iNKT cells to maintain immune homeostasis in acute inflammatory conditions but drives proinflammatory effector T cell infiltration in chronic inflammatory reactions. This proinflammatory NKT cell function might synergize with the function of matured DCs in chronic inflammation at aggravating GN.12

Regulatory T cells are widely recognized as being protective in various immune-mediated diseases.37 In NTN, these cells, under the control of CCR6 and CCR7,38,39 were also found to attenuate disease.4042 Our present study highlights iNKT cells as a second regulatory lymphocyte subset that can protect against renal tissue injury in experimental GN and also shows that it is under control of a different chemokine system, the CXCR6–CXCL16 axis. However, the extrapolation of findings from murine crescentic GN to the immunopathogenesis of human rapidly progressive glomerulonephritis is restricted, because human iNKT cells present phenotypic differences relative to their murine counterpart. A better understanding of human iNKT cell biology in autoimmune disease, such as the different forms of crescentic GN, is needed before the manipulation of iNKT cells might represent a new therapeutic target in humans.

Concise Methods

Animals

CXCR6-deficient mice (C57BL/6 background)43 were purchased from The Jackson Laboratory (Bar Harbor, ME), and the CXCR6−/− genotype was confirmed by PCR analysis in each animal before experimental use. DC depletion in CD11c.LuciDTR mice has been described recently.17 Knockout mice underwent embryo transfer to meet the general standards of our institution. Age-matched C57BL/6 wild-type controls also derived from the strain were bred in our animal facility, and all animals were raised in specific pathogen-free conditions. All animal experiments were performed according to national and institutional animal care and ethical guidelines and were approved by the local committees.

Induction of NTN and Functional Studies

Nephrotoxic serum nephritis was induced in 8- to 12-week-old male CXCR6-deficient and wild-type mice by intraperitoneal injection of 0.5 ml NTN serum/mouse as previously described.40 Controls were injected intraperitoneally with an equal amount of nonspecific sheep IgG. For urine sample collection, mice were housed in metabolic cages for 6 hours. Urinary albumin excretion was determined by standard ELISA analysis (Mice Albumin Kit, Bethyl), whereas urinary creatinine, BUN, and serum creatinine were measured using standard laboratory methods.

Real-Time RT-PCR Analysis

Total RNA of the renal cortex was prepared from murine kidneys according to standard laboratory methods. RNA from FACS-sorted iNKT cells was extracted using an RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. RT-PCR was performed for 40 cycles (primer sequences are available on request) in a Step One Plus RT-PCR System (Applied Biosystems, Foster City, CA) as previously described.44 All samples were run in duplicate and normalized to 18S rRNA.

In Situ Hybridization

In situ hybridization procedures were performed as previously described.44 In brief, the CXCL16 cRNA probe was labeled by in vitro transcription (Maxiscript Ambion) with α[35S]-UTP (1250 Ci/mmol; PerkinElmer) of subcloned cDNA corresponding to nucleotides 503–820 of cDNA sequence NM_023158. In situ hybridization was performed on 16-µm cryosections using 1×106 cpm/slide of the 35S-labeled antisense or sense RNA probes. After washing, sections were dipped into Kodak NTB nuclear track emulsion and stained with Mayer’s Haemalaun.

Morphologic Examinations

Crescent formation and glomerular sclerosis (deposition of PAS-positive material) were assessed in 50 glomeruli per mouse in a blinded fashion in PAS-stained paraffin sections. As a measure of tubulointerstitial injury, the interstitial area was estimated by point counting four independent areas of renal cortex per mouse in low magnification fields (200×) as previously described.21 Paraffin-embedded sections (2 µm) were stained with an antibody directed against CD3 (A0452; Dako, Germany), FoxP3 (FJK-16s; eBiosciences, San Diego, CA), F4/80 (BM8; BMA, Germany), MAC-2 (M3/38; Cedarlane, Canada), CD11c (M17/4; BD Pharmingen, Germany), and sheep IgG or mouse IgG (Jackson Immunoresearch Laboratories). Tissue sections were developed using the Vectastain ABC-AP kit (Vector Laboratories, Burlingame, CA). For FoxP3 staining, tissue sections were incubated with a polyclonal rabbit anti-rat secondary antibody (Dako, Germany) and developed using the ZytoChem Plus (AP) Polymer Kit (Zytomed). MAC-2+ and CD3+ cells in 30 glomerular cross-sections and F4/80+ and CD3+ cells in 30 tubulointerstitial hpf (magnification=400×) per kidney were counted by light microscopy in a blinded fashion. For the quantification of FoxP3+ cells, at least 10 low power fields (magnification=200×) were counted.40 Glomerular mouse IgG deposition was scored from zero to three in 30 glomeruli per mouse as previously described.38

Assessment of the Humoral and Cellular Nephritogenic Immune Responses

Mouse anti-sheep IgG antibody titers were measured by ELISA using sera collected 8 days after induction of nephritis as previously described.40 To analyze the cellular immune response, splenocytes (4×106 cells/ml) were cultured in RPMI/10% FCS with sheep IgG (10 μg/ml) at 37°C for 72 hours. IFNγ and IL-17A concentrations were measured in the supernatants by ELISA as previously described.40

Renal Leukocyte Isolation

Previously described methods for leukocyte isolation from murine kidneys were used.45 In brief, kidneys were finely minced and digested for 45 minutes at 37°C with 0.4 mg/ml collagenase D (Roche, Mannheim, Germany) and 0.01 mg/ml DNAse I in RPMI 1640 (Roche) supplemented with 10% heat-inactivated FCS (Invitrogen). Cell suspensions were sequentially filtered through 70- and 40-µm nylon meshes and washed with HBSS without Ca2+ and Mg2+ (Invitrogen). Single-cell suspensions were separated using Percoll density gradient (70% and 40%) centrifugation. The leukocyte-enriched cell suspension was aspirated from the Percoll interface. Cell viability was assessed by trypan blue staining before flow cytometry.

Isolation of Hepatic Leukocytes and Splenocytes and Renal DC Isolation

To isolate hepatic leukocytes, livers were passed through 100-μm nylon meshes, and hepatocytes were removed by centrifugation (800×g for 20 minutes) in 37% Percoll solution (Amersham-Biosciences, Freiburg, Germany) containing 100 U/ml heparin at room temperature. For the isolation of splenocytes, spleens were minced and sequentially passed through 70- and 40-μm nylon meshes on ice. After removing the erythrocytes from both cell suspensions using lysis solution (139 mM NH4Cl, 19 mM Tris), cells were washed with HBSS and resuspended in FCS-containing buffer. For the isolation of DCs, tissue was digested, and renal single-cell suspensions were resuspended in MACS buffer (500 ml PBS, 0.1% BSA, 2 mM EDTA) and coincubated with mouse-CD11c MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). After incubation, DCs were positively separated using MACS LS Separation Columns (Miltenyi Biotec, Bergisch Gladbach, Germany). Renal DCs were resuspended in PBS for additional analysis.

Flow Cytometry

For FACS analysis, renal leukocyte suspensions were stained at 4°C for 20 minutes using the following fluorochrome-conjugated antibodies: CD45 (30-F11), CD3 (17A2), CD4 (GK1.5), CD8 (53–6.7), CD25 (PC61.5), CD11b (M1/70), CD19 (1D3), TCRβ (H57–597), CD11c(HL3), and NK1.1 (PK136; BD Biosciences, Franklin Lakes, NJ or eBioscience, San Diego, CA). Staining of renal leukocytes using commercially available CXCR6 antibodies resulted in unacceptably high background signals in CXCR6-deficient mice (data not shown); CXCR6 receptor expression was, therefore, detected by using a well characterized CXCL16-Fc fusion protein23 and a phycoerythrin-labeled F(ab′)2 goat anti-human Fcγ polyclonal Ab (Jackson ImmunoResearch Europe, Suffolk, United Kingdom). For the staining of iNKT cells, antigen-presenting cell-labeled CD1d tetramers loaded with the α-Gal-Cer analog PBS57 were obtained from the National Institutes of Health Tetramer Core Facility (Emory Vaccine Center at Yerkes, Emory University, Atlanta, GA). Unloaded tetramers were used as a control. Before antibody incubation, unspecific staining was blocked with normal mouse serum (Sigma). Staining of intracellular IFNγ (XMG1.2), IL-4 (11B11), and IL-17 (TC11–18H10) was performed as recently described.38 Analyses were performed on a Becton & Dickinson LSRII System.

NKT Cell Transfer Experiments

Liver CD45+TCRβ+NK1.1+CD19 NKT cells were isolated using a FACS Aria sorter as previously described.46 Wild-type and CXCR6-deficient mice were intravenously injected with 1×106 isolated cells in 250 μl PBS per animal followed by induction of nephritis after 12 hours.

In Vitro NKT Cell Stimulation Assays

NKT cells were isolated as described above, seeded in 96-well cell culture plates (0.8×105 cells/well) together with bone marrow-derived DCs (0.4×105 cells/well), which were used as α-GalCer–presenting cells, and stimulated with 15 ng/ml α-GalCer. After 72 hours, the cytokine concentrations in the supernatant were determined by Cytometric Bead Array according to the manufacturer’s instructions (Becton & Dickinson).

Statistical Analyses

The results are shown as the mean ± SD when presented as a bar graph and the mean with the median when presented as single data points in a scatter dot plot. The results reported in the text are the mean ± SD. Differences between two individual experimental groups were compared using a two-tailed t test. For multiple comparisons, the one-way ANOVA with Bonferroni multiple comparisons test was used. Experiments that did not yield enough independent data for statistical analysis because of the experimental setup were repeated at least three times.

Disclosures

None.

Supplementary Material

Supplemental Data

Acknowledgments

We thank Dr. Mehrdad Matloubian (University of California, San Francisco, CA) for the kind gift of the CXCL16-Fc fusion protein, Dr. Carsten Wiethe for myeloid dendritic cell preparation, and Anett Peters and Sabrina Bennstein for their excellent technical help. Sorting of cell subsets was performed by the FACS Sorting Core Unit at Universitätsklinikum Hamburg-Eppendorf.

This study was supported by Deutsche Forschungsgemeinschaft Grants KFO 0228 PA 754/7-1 (to J.-E.T. and U.P.) and KU 1063/7-1 (to C.K.).

Footnotes

Published online ahead of print. Publication date available at www.jasn.org.

References

  • 1.Chadban SJ, Atkins RC: Glomerulonephritis. Lancet 365: 1797–1806, 2005 [DOI] [PubMed] [Google Scholar]
  • 2.Tarzi RM, Cook HT, Pusey CD: Crescentic glomerulonephritis: New aspects of pathogenesis. Semin Nephrol 31: 361–368, 2011 [DOI] [PubMed] [Google Scholar]
  • 3.Bolton WK: Rapidly progressive glomerulonephritis. Semin Nephrol 16: 517–526, 1996 [PubMed] [Google Scholar]
  • 4.Couser WG: Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 23: 381–399, 2012 [DOI] [PubMed] [Google Scholar]
  • 5.Tipping PG, Huang XR, Qi M, Van GY, Tang WW: Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 152: 1541–1548, 1998 [PMC free article] [PubMed] [Google Scholar]
  • 6.Tipping PG, Holdsworth SR: T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17: 1253–1263, 2006 [DOI] [PubMed] [Google Scholar]
  • 7.Turner JE, Paust HJ, Steinmetz OM, Panzer U: The Th17 immune response in renal inflammation. Kidney Int 77: 1070–1075, 2010 [DOI] [PubMed] [Google Scholar]
  • 8.Kitching AR, Holdsworth SR: The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 22: 235–238, 2011 [DOI] [PubMed] [Google Scholar]
  • 9.Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, Krebs C, Velden J, Mittrücker HW, Steinmetz OM, Stahl RA, Panzer U: Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int 82: 72–83, 2012 [DOI] [PubMed] [Google Scholar]
  • 10.Lukacs-Kornek V, Engel D, Tacke F, Kurts C: The role of chemokines and their receptors in dendritic cell biology. Front Biosci 13: 2238–2252, 2008 [DOI] [PubMed] [Google Scholar]
  • 11.Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, Hammerich L, Panzer U, Kaden S, Quaggin SE, Floege J, Gröne HJ, Kurts C: Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 119: 1286–1297, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hochheiser K, Engel DR, Hammerich L, Heymann F, Knolle PA, Panzer U, Kurts C: Kidney dendritic cells become pathogenic during crescentic glomerulonephritis with proteinuria. J Am Soc Nephrol 22: 306–316, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Scholz J, Lukacs-Kornek V, Engel DR, Specht S, Kiss E, Eitner F, Floege J, Groene HJ, Kurts C: Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol 19: 527–537, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bretscher P, Cohn M: A theory of self-nonself discrimination. Science 169: 1042–1049, 1970 [DOI] [PubMed] [Google Scholar]
  • 15.Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 21: 685–711, 2003 [DOI] [PubMed] [Google Scholar]
  • 16.Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, Griffin MD: Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 71: 619–628, 2007 [DOI] [PubMed] [Google Scholar]
  • 17.Tittel AP, Heuser C, Ohliger C, Llanto C, Yona S, Hämmerling GJ, Engel DR, Garbi N, Kurts C: Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat Methods 9: 385–390, 2012 [DOI] [PubMed] [Google Scholar]
  • 18.Yang SH, Kim SJ, Kim N, Oh JE, Lee JG, Chung NH, Kim S, Kim YS: NKT cells inhibit the development of experimental crescentic glomerulonephritis. J Am Soc Nephrol 19: 1663–1671, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mesnard L, Keller AC, Michel ML, Vandermeersch S, Rafat C, Letavernier E, Tillet Y, Rondeau E, Leite-de-Moraes MC: Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol 20: 1282–1292, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kim CH, Johnston B, Butcher EC: Trafficking machinery of NKT cells: Shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11–16, 2002 [DOI] [PubMed] [Google Scholar]
  • 21.Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U: CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol 183: 4693–4704, 2009 [DOI] [PubMed] [Google Scholar]
  • 22.Godfrey DI, Stankovic S, Baxter AG: Raising the NKT cell family. Nat Immunol 11: 197–206, 2010 [DOI] [PubMed] [Google Scholar]
  • 23.Matloubian M, David A, Engel S, Ryan JE, Cyster JG: A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1: 298–304, 2000 [DOI] [PubMed] [Google Scholar]
  • 24.Johnston B, Kim CH, Soler D, Emoto M, Butcher EC: Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol 171: 2960–2969, 2003 [DOI] [PubMed] [Google Scholar]
  • 25.Jiang X, Shimaoka T, Kojo S, Harada M, Watarai H, Wakao H, Ohkohchi N, Yonehara S, Taniguchi M, Seino K: Cutting edge: Critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 175: 2051–2055, 2005 [DOI] [PubMed] [Google Scholar]
  • 26.Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B: Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol 181: 81–91, 2008 [DOI] [PubMed] [Google Scholar]
  • 27.Schramme A, Abdel-Bakky MS, Gutwein P, Obermüller N, Baer PC, Hauser IA, Ludwig A, Gauer S, Schäfer L, Sobkowiak E, Altevogt P, Koziolek M, Kiss E, Gröne HJ, Tikkanen R, Goren I, Radeke H, Pfeilschifter J: Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney. Kidney Int 74: 328–338, 2008 [DOI] [PubMed] [Google Scholar]
  • 28.Gutwein P, Abdel-Bakky MS, Schramme A, Doberstein K, Kämpfer-Kolb N, Amann K, Hauser IA, Obermüller N, Bartel C, Abdel-Aziz AA, El Sayed SM, Pfeilschifter J: CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol 174: 2061–2072, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Segerer S, Heller F, Lindenmeyer MT, Schmid H, Cohen CD, Draganovici D, Mandelbaum J, Nelson PJ, Gröne HJ, Gröne EF, Figel AM, Nössner E, Schlöndorff D: Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 74: 37–46, 2008 [DOI] [PubMed] [Google Scholar]
  • 30.Kitching AR, Tipping PG, Mutch DA, Huang XR, Holdsworth SR: Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int 53: 112–118, 1998 [DOI] [PubMed] [Google Scholar]
  • 31.Kitching AR, Tipping PG, Huang XR, Mutch DA, Holdsworth SR: Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 52: 52–59, 1997 [DOI] [PubMed] [Google Scholar]
  • 32.Jiang X, Sun W, Zhu L, Guo D, Jiang H, Ma D, Jin J, Zhao Y, Liang J: Expression of CXCR6 on CD8(+) T cells was up-regulated in allograft rejection. Transpl Immunol 22: 179–183, 2010 [DOI] [PubMed] [Google Scholar]
  • 33.Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, Bruce A, Weber C, Ley K: CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 116: 1801–1811, 2007 [DOI] [PubMed] [Google Scholar]
  • 34.van der Voort R, van Lieshout AW, Toonen LW, Slöetjes AW, van den Berg WB, Figdor CG, Radstake TR, Adema GJ: Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 52: 1381–1391, 2005 [DOI] [PubMed] [Google Scholar]
  • 35.Garcia GE, Truong LD, Li P, Zhang P, Johnson RJ, Wilson CB, Feng L: Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. Am J Pathol 170: 1485–1496, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chen G, Lin SC, Chen J, He L, Dong F, Xu J, Han S, Du J, Entman ML, Wang Y: CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 22: 1876–1886, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wing K, Sakaguchi S: Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11: 7–13, 2010 [DOI] [PubMed] [Google Scholar]
  • 38.Turner JE, Paust HJ, Steinmetz OM, Peters A, Riedel JH, Erhardt A, Wegscheid C, Velden J, Fehr S, Mittrücker HW, Tiegs G, Stahl RA, Panzer U: CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 21: 974–985, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Eller K, Weber T, Pruenster M, Wolf AM, Mayer G, Rosenkranz AR, Rot A: CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J Am Soc Nephrol 21: 42–52, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Paust HJ, Ostmann A, Erhardt A, Turner JE, Velden J, Mittrücker HW, Sparwasser T, Panzer U, Tiegs G: Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Kidney Int 80: 154–164, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ooi JD, Snelgrove SL, Engel DR, Hochheiser K, Ludwig-Portugall I, Nozaki Y, O’Sullivan KM, Hickey MJ, Holdsworth SR, Kurts C, Kitching AR: Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney Int 79: 977–986, 2011 [DOI] [PubMed] [Google Scholar]
  • 42.Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR: CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16: 1360–1370, 2005 [DOI] [PubMed] [Google Scholar]
  • 43.Unutmaz D, Xiang W, Sunshine MJ, Campbell J, Butcher E, Littman DR: The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol 165: 3284–3292, 2000 [DOI] [PubMed] [Google Scholar]
  • 44.Turner JE, Paust HJ, Steinmetz OM, Peters A, Meyer-Schwesinger C, Heymann F, Helmchen U, Fehr S, Horuk R, Wenzel U, Kurts C, Mittrücker HW, Stahl RA, Panzer U: CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol 181: 6546–6556, 2008 [DOI] [PubMed] [Google Scholar]
  • 45.Panzer U, Steinmetz OM, Paust HJ, Meyer-Schwesinger C, Peters A, Turner JE, Zahner G, Heymann F, Kurts C, Hopfer H, Helmchen U, Haag F, Schneider A, Stahl RA: Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol 18: 2071–2084, 2007 [DOI] [PubMed] [Google Scholar]
  • 46.Biburger M, Tiegs G: Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 84: 264–279, 2008 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from Journal of the American Society of Nephrology : JASN are provided here courtesy of American Society of Nephrology

RESOURCES